跳转到主要内容

促进儿科肿瘤药物开发

Our speakers will discuss the pediatric oncology regulatory landscape and how modeling and simulation is used in pediatric oncology drug development.

Can Modeling & Simulation Inform Personalized Medicine?

Pharma faces an existential crisis. The cost and time lines of developing new medications have been growing exponentially for decades, with no end in sight. Could modeling and simulation approaches be the Next Great Hope for ending this madness and restoring sustainability to drug development? At the same time, can it deliver on the promise of … Continued

1 of 1

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software